Open a section to read the detail.
Krebs Biochemicals and Industries (KREBSBIO) share price is tracked live on this page, with the intraday move, day range, historical chart, financial results, shareholding pattern and technical levels for both NSE and BSE.
KREBSBIO has been listed on the NSE since 3 January 1996 and trades under ISIN INE268B01013, with a face value of ₹10. It is classified by the NSE under Capital Goods.
Prices update through the trading session. Figures on this page are for information only and are not a recommendation to buy or sell.
| Company | Krebs Biochemicals and Industries |
|---|---|
| NSE symbol | KREBSBIO |
| Sector | Capital Goods |
| ISIN | INE268B01013 |
| Listed on NSE | 3 January 1996 |
| Face value | ₹10 |
| Series | EQ (rolling settlement, intraday allowed) |
| Exchanges | NSE and BSE |
| Previous close | ₹55.48 |
| 52-week range | ₹38.33 – ₹82.49 |
The live Krebs Biochemicals and Industries (KREBSBIO) share price above shows the last traded price, the change and percentage change for the session, and the day's open, high, low and previous close. Use the exchange toggle to switch between the NSE and BSE quote.
The interactive chart plots KREBSBIO across intraday, daily, weekly and monthly timeframes, so you can read the Krebs Biochemicals and Industries share price history over any period and compare it against index or peer performance.
The financials tab carries the quarterly and annual results for Krebs Biochemicals and Industries — revenue, operating profit, net profit and earnings per share — alongside the balance sheet and cash-flow statements, so you can follow how each KREBSBIO result compares with earlier periods.
The shareholding pattern shows how Krebs Biochemicals and Industries equity is split between promoters, foreign institutional investors, domestic institutions and public shareholders, with the quarter-on-quarter change in each holding as filed with the exchanges.
Corporate actions for KREBSBIO — dividends declared and their ex-dates, along with any bonus issue, stock split or rights issue Krebs Biochemicals and Industries has announced — are listed with the record dates the exchanges published.
Over the last year Krebs Biochemicals and Industries (KREBSBIO) has traded between ₹38.33 and ₹82.49. The 52-week range is the simplest read on where the current price sits against its own recent history.
Technical levels for KREBSBIO include moving averages, RSI, MACD and classic, Fibonacci and Camarilla pivot tables, plus the 52-week high and low, to help frame support and resistance around the current Krebs Biochemicals and Industries share price.
The live Krebs Biochemicals and Industries (KREBSBIO) price is shown at the top of this page, together with the day's change, open, high, low and previous close for both NSE and BSE. It updates through the trading session.
Krebs Biochemicals and Industries trades on the NSE under the symbol KREBSBIO, with ISIN INE268B01013 in the EQ series.
Krebs Biochemicals and Industries (KREBSBIO) has been listed on the National Stock Exchange since 3 January 1996. Its shares carry a face value of ₹10.
The financials section on this page carries Krebs Biochemicals and Industries's quarterly and annual results, balance sheet and cash-flow statements, so you can compare each KREBSBIO reporting period against the last.
Any dividend, bonus issue or stock split Krebs Biochemicals and Industries has declared appears in the corporate actions section on this page, with the ex-date and record date as published by the exchanges.
The shareholding section breaks KREBSBIO down by promoter, foreign institutional, domestic institutional and public holding, with the change from the previous quarter.
The NSE classifies Krebs Biochemicals and Industries under Capital Goods. You can compare it against other Capital Goods stocks from the sector peers listed on this page.
You need a trading and demat account to buy KREBSBIO on the NSE or BSE. Once your account is active you can place a buy or sell order from this page. Nothing here is a recommendation — please make your own assessment.